Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-36,191
Closed -$2.78M 452
2022
Q1
$2.78M Sell
36,191
-1,920
-5% -$138K 0.02% 482
2021
Q4
$2.92M Sell
38,111
-1,321
-3% -$97.1K 0.02% 494
2021
Q3
$2.91M Sell
39,432
-1,134
-3% -$85K 0.03% 467
2021
Q2
$2.71M Sell
40,566
-182,480
-82% -$12.2M 0.03% 486
2021
Q1
$16.6M Sell
223,046
-35,974
-14% -$2.73M 0.12% 180
2020
Q4
$18.9M Sell
259,020
-50,644
-16% -$3.58M 0.13% 172
2020
Q3
$20.6M Buy
309,664
+174,020
+128% +$11M 0.14% 157
2020
Q2
$7.73M Sell
135,644
-88,883
-40% -$4.36M 0.06% 335
2020
Q1
$7.88M Buy
224,527
+5,611
+3% +$267K 0.07% 311
2019
Q4
$11.4M Sell
218,916
-254,900
-54% -$12.7M 0.08% 293
2019
Q3
$23.9M Buy
473,816
+278,965
+143% +$13.7M 0.15% 171
2019
Q2
$9.36M Sell
194,851
-22,483
-10% -$1.04M 0.06% 354
2019
Q1
$10.5M Buy
217,334
+100,986
+87% +$4.55M 0.08% 308
2018
Q4
$4.78M Sell
116,348
-145,883
-56% -$5.98M 0.04% 484
2018
Q3
$10.7M Buy
262,231
+218,045
+493% +$8.81M 0.08% 292
2018
Q2
$1.76M Sell
44,186
-2,217
-5% -$85.3K 0.01% 803
2018
Q1
$1.73M Buy
+46,403
New +$1.88M 0.01% 828

Other funds holding HOLX

Mackay Shields LLC's HOLX Position: Q2 2022 in Review

Mackay Shields LLC sold out of Hologic (HOLX) in Q2 2022, closing a stake of 36,191 shares — an estimated $2.78M sold.

Mackay Shields LLC first reported a position in HOLX in Q1 2018 and held it in 17 quarters. The position peaked at $23.9M in Q3 2019. 694 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

  • Mackay Shields LLC reported no remaining Hologic position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 36,191 Hologic shares in Q2 2022, an estimated $2.78M.
  • Mackay Shields LLC first reported a position in Hologic in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's Hologic position peaked at $23.9M in Q3 2019.
  • 694 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.